Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for HeartSciences Inc. (HSCS : NSDQ)

• Company Description    Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $3.57 Daily Weekly Monthly 20 Day Moving Average: 46,311 shares Shares Outstanding: 1.08 (millions) Market Capitalization: $3.86 (millions) Beta: 2.57 52 Week High: $5.30 52 Week Low: $2.36 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.28% -4.71% 12 Week 3.48% -11.62% Year To Date -6.54% -12.46%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 550 RESERVE ST SUITE 360 - SOUTHLAKE,TX 76092 USA ph: 682-237-7781 fax: - investorrelations@heartsciences.com https://heartsciences.com

• General Corporate Information    Officers Andrew Simpson - President; Chief Executive Officer and Chairman Mark Hilz - Chief Operating Officer; Secretary and Director Danielle Watson - Chief Financial Officer and Treasurer Bruce Bent - Director David R. Wells - Director Peer Information HeartSciences Inc. (HLIS) HeartSciences Inc. (AZTA) HeartSciences Inc. (APYI) HeartSciences Inc. (RNVA) HeartSciences Inc. (HMSY) HeartSciences Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 42254E302 SIC: 3842 Fiscal Year Fiscal Year End: April Last Reported Quarter: 01/01/25 Next Expected EPS Date: 08/04/25 Share - Related Items Shares Outstanding: 1.08 Most Recent Split Date: 5.00 (0.01:1) Beta: 2.57 Market Capitalization: $3.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-2.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-9.78 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.96 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 14.33% vs. Previous Quarter: -13.22% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 04/30/25 - - 01/31/25 - -178.80 10/31/24 - -117.76 ROA 04/30/25 - - 01/31/25 - -109.28 10/31/24 - -84.09 Current Ratio 04/30/25 - - 01/31/25 - 1.02 10/31/24 - 1.72 Quick Ratio 04/30/25 - - 01/31/25 - 0.83 10/31/24 - 1.52 Operating Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Net Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Pre-Tax Margin 04/30/25 - - 01/31/25 - - 10/31/24 - -50,833.34 Book Value 04/30/25 - - 01/31/25 - 1.82 10/31/24 - 4.40 Inventory Turnover 04/30/25 - - 01/31/25 - 0.00 10/31/24 - 0.01 Debt-to-Equity 04/30/25 - - 01/31/25 - 0.00 10/31/24 - 0.01 Debt-to-Capital 04/30/25 - - 01/31/25 - 0.00 10/31/24 - 1.22

Powered by Zacks Investment Research ©